Rafarma Establishes Advisory Board, Appoints First Member and Will Acquire Additional Patents and Intellectual Property

NEXT STORY
Onxeo to Receive $6.6 Million by Granting Additional Exclusive Rights to Belinostat to Acrotech Biopharma LLC
PREV STORY
BrightInsight Named 2019 Google Cloud Technology Partner of the Year for the Healthcare Industry for Second Year in Row
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

MDxHealth Provides First Quarter 2016 Business Update

IRVINE, Calif. and HERSTAL, Belgium, May 3, 2016 (GLOBE NEWSWIRE) -- MDxHealth SA (Euronext: ...

author_avatar
NASDAQ Market News

Argos Therapeutics Announces Publication of a Case Report on Long-term Survival of Kidney Cancer Patients Treated with AGS-003 Individualized Immunotherapy Featured in the Kidney Cancer Journal

Two advanced kidney cancer patients from a Phase 2 clinical trial maintain ongoing control ...

author_avatar
NASDAQ Market News

Telix Pharmaceuticals and JFE Progress Japanese Manufacturing Partnership

MELBOURNE, Australia and TOKYO, July 26, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX:TLX) ...

author_avatar
NASDAQ Market News